Gaucher disease: forging a new path to the lysosome
- PMID: 18022357
- DOI: 10.1016/j.cell.2007.10.043
Gaucher disease: forging a new path to the lysosome
Abstract
Most lysosomal proteins are tagged with a carbohydrate modification that allows their recognition and transport to the lysosome. In this issue, Reczek et al. (2007) identify a new pathway for protein sorting to the lysosome. They show that beta-glucocerebrosidase-the lysosomal enzyme defective in patients with Gaucher disease-is delivered to the lysosome through its interaction with the transmembrane protein LIMP-2.
Comment on
-
LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase.Cell. 2007 Nov 16;131(4):770-83. doi: 10.1016/j.cell.2007.10.018. Cell. 2007. PMID: 18022370
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous